Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00017394
Status:
COMPLETED
Last Update Posted:
2013-01-17
First Post:
2001-06-06
Brief Title:
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| Male Breast Cancer |
| Recurrent Breast Cancer |
Keywords: